Monitoring Asthma and COPD in Primary Care (Monaco)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00542061|
Recruitment Status : Completed
First Posted : October 10, 2007
Last Update Posted : March 9, 2010
|Condition or disease||Intervention/treatment||Phase|
|Lung Diseases, Obstructive Asthma||Device: half-yearly monitoring routine||Not Applicable|
In the Netherlands, the majority of patients (60-80 %) with asthma or COPD are treated in primary care, primarily by General Practitioners (GPs). In 1995 a Regional Diagnostic Centre, Etten-Leur, The Netherlands (also called SHL: Stichting Huisartsen Laboratorium) started a lung function monitoring service for patients with asthma and COPD of GPs in the region. The GP receives recommendations on treatment, additional diagnostics and referrals of the patient based on extensive anamnesis (i.e. dyspnoea, symptoms, smoking stage), measurement of lung function, and BMI. Moreover,the general practitioners are supported by an Asthma/COPD nurse that visit the general practice half-yearly.
Main research question of this study: Is a written expert advice for GPs on additional diagnostic, treatment, and referral of patients based on half-yearly monitoring of patients with COPD or asthma with a persistent airway obstruction with support of an AC nurse consultant related to less impaired health related quality of life (HRQoL), less symptoms and better lung function of the patients compared to usual care?
A multi-centre, single blinded (patient, lung function assistant, advisor, and research team are blinded), parallel group study is carried out to compare the monitoring intervention with usual care during 24 months. General practices were allocated by a minimisation procedure and all participating patients of a general practice were allocated to the same treatment group (nested design).
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Clinical Effectiveness and Cost-effectiveness of a Monitoring System for Patients With COPD and Asthma With Persistent Obstruction in Primary Care; a Multicentre Randomised Nested Clinical Trial|
|Study Start Date :||March 2005|
|Actual Primary Completion Date :||February 2007|
|Actual Study Completion Date :||April 2008|
Device: monitoring services
Device: half-yearly monitoring routine
A written expert advice for GPs on additional diagnostic, treatment, and referral of patients with asthma and COPD based on half-yearly monitoring routines (lung function assessments including extensive anamnese) supported by half-yearly visits of an AC nurse consultant to the general practices.
No Intervention: B
Control group: no monitoring procedures
- Disease-specific health related quality of life assessed with the Chronic Respiratory Questionnaire (CRQ-SR) [ Time Frame: At baseline, after one year follow-up, and after two years follow-up ]
- Number of exacerbations; generic HRQoL (SF12); lung function indices; level of respiratory symptoms (MRC); satisfaction with the health care received (EuroPep); direct and indirect medical costs. [ Time Frame: Yearly: SF12, MRC, exacerbations; At baseline and end of the trial: EuroPEP, lung function indices; Continues by general practitioner registration: costs and exacerbations ]
- Moreover special attention will be paid to process evaluation (e.g, compliance to recommendations by general practitioner and patients). [ Time Frame: half-yearly for general practitioners and yearly for patients ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00542061
|Regional Diagnostic Centre, Etten-Leur, The Netherlands (SHL)|
|Study Director:||Tjard Schermer, PhD||Radboud University Nijmegen Medical Centre, department of general practice|
|Principal Investigator:||Lisette van den Bemt, MSc||Radboud University Nijmegen Medical Centre, department of general practice|
|Study Chair:||Chris van Weel, MD PhD professor||Radboud University Nijmegen Medical Centre, department of general practice|